To provide an update on the clinical burden of calcinosis (subcutaneous or intracutaneous deposition of calcium salts) in patients with systemic sclerosis (SSc), and discuss advances in our understanding of pathogenesis, associates, and measurement techniques, as well as an overview of the current approach to management.
Methods
Four case scenarios are presented, to illustrate the clinical spectrum of calcinosis. Epidemiology (including associates), pathogenesis, imaging and measurement, and treatment are reviewed.
Results
Calcinosis represents a major clinical problem in patients with SSc. Up to 40% of patients are affected, the proportion depending in part on how carefully calcinosis is looked for. Associates of calcinosis include longer disease duration, anticentromere antibody, and digital ulceration. When severe, calcinosis causes pain, disability, and disfigurement. Pathogenesis is unknown, but tissue ischaemia, microtrauma, and loss of balance between calcification stimulants and inhibitors are likely contributors. Calcinosis deposits are mainly composed of hydroxyapatite. They are very visible on plain radiographs, and radiographic scoring systems are being developed, and other imaging modalities (including computed tomography and ultrasound) are being explored. Despite a number of proposed treatments, currently there is no effective ‘disease-modifying’ therapy for calcinosis and the main aspects of management are antibiotics, analgesics, multidisciplinary team input, and surgical debulking.
Conclusions
Up until recently, SSc-related calcinosis has received very little attention in terms of research into pathogenesis, measurement, and treatment. This imbalance is now being redressed and although we still do not have an effective treatment, progress is being made.
SteenVDZieglerGLRodnanGPMedsgerTAJrClinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.Arthritis Rheum1984;27:(2)125-131
2.
AkessonAWollheimFAOrgan manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma.Br J Rheumatol1989;28:(4)281-286
3.
TagerRETiklyMClinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans.Rheumatology (Oxford)1999;38:(5)397-400
4.
AvouacJGueriniHWipffJet al.Radiological hand involvement in systemic sclerosis.Ann Rheum Dis2006;65:(8)1088-1092
5.
MahmoodMWilkinsonJManningJHerrickALHistory of surgical debridement, anticentromere antibody, and disease duration are associated with calcinosis in patients with systemic sclerosis.Scand J Rheumatol2016;45:(2)114-117
6.
ValenzuelaABaronMthe Canadian Scleroderma Research Group, et al. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a Scleroderma Clinical Trial Consortium Study.Semin Arthritis Rheum2016Jun2pii: S0049-0172(16)30060-9. [Epub ahead of print]
7.
HughesMFreemontTJDentonJHerrickALInfected calcinosis of the knee in limited cutaneous systemic sclerosis.J Rheumatol2012;39:(10)2043-2044
8.
NishikaiMItohKSatoACalcinosis and the anticentromere antibody: its clinical, radiological and immunogenetic aspects.Br J Rheumatol1992;31:(1)9-12
9.
JacobsenSHalbergPUllmanSet al.Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis.Br J Rheumatol1998;37:(1)39-45
10.
VayssairatMHidoucheDAbdoucheli-BaudotNGaitzJPClinical significance of subcutaneous calcinosis in patients with systemic sclerosis.Does diltiazem induce its regression? Ann Rheum Dis1998;57:(4)252-254
11.
KoschikRWIIFertigNLucasMRDomsicRTMedsgerTAJrAnti-PM-Scl antibody in patients with systemic sclerosis.Clin Exp Rheumatol2012;302 Suppl 71S12-S16
12.
D'AoustJHudsonMTatibouetSet al;Canadian Scleroderma Research Group.Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheum (Munch)2014;66:(6)1608-1615
13.
BrennanKJacksonSHerrickALCalcinosis in systemic sclerosis - are we underestimating its prevalence? Abstracts of the British Society for Rheumatology Annual Meeting 20-23 April 2004.Rheumatology2004;43Suppl 2ii98Abstract no. 223. Available from: http://rheumatology.oxfordjournals.org/content/43/suppl_2.toc. Accessed Jun 20, 2016.
14.
Sari-KouzelHHutchinsonCEMiddletonAet al.Foot problems in patients with systemic sclerosis.Rheumatology (Oxford)2001;40:(4)410-413
15.
BlaneCEWhiteSJBraunsteinEMBowyerSLSullivanDBPatterns of calcification in childhood dermatomyositis.AJR Am J Roentgenol1984;142:(2)397-400
16.
ShahiVWetterDAHoweBMRinglerMDDavisMDPlain radiography is effective for the detection of calcinosis cutis occurring in association with autoimmune connective tissue disease.Br J Dermatol2014;170:(5)1073-1079
17.
SchweitzerMECervillaVManasterBJet al.Cervical paraspinal calcification in collagen vascular diseases.AJR Am J Roentgenol1991;157:(3)523-525
18.
WardMCuréJSchabelSSmithEASchumacherHRJrSilverRMSymptomatic spinal calcinosis in systemic sclerosis (scleroderma).Arthritis Rheum1997;40:(10)1892-1895
19.
ArginteanuMSPerinNIParaspinal calcinosis associated with progressive systemic sclerosis.Case report. J Neurosurg1997;87:(5)761-763
20.
LimaIVGalrãoLAMaiaTSSantiagoMBSpinal cord compression by ectopic calcinosis in scleroderma.Clin Exp Rheumatol2005;23:(5)704-706
21.
SmuckerJDHellerJGBohlmanHHWhitesidesTEJr.Surgical treatment of destructive calcific lesions of the cervical spine in scleroderma: case series and review of the literature.Spine2006;31:(17)2002-2008
22.
WeerakoonASharpDChapmanJClunieGLumbar canal spinal stenosis due to axial skeletal calcinosis and heterotopic ossification in limited cutaneous systemic sclerosis: successful spinal decompression.Rheumatology (Oxford)2011;50:(11)2144-2146
23.
BluettJDaviesCHarrisJHerrickACervical spine calcinosis in systemic sclerosis.J Rheumatol2013;40:(9)1617-1618
24.
SambataroDSambataroGZaccaraEMaglioneWVitaliCDel PapaNTumoral calcinosis of the spine in the course of systemic sclerosis: report of a new case and review of the literature.Clin Exp Rheumatol2015;334 Suppl 91S175-S178
25.
ResnickDScavulliJFGoergenTGGenantHKNiwayamaGIntra-articular calcification in scleroderma.Radiology1977;124:(3)685-688
26.
BrandtKDKreyPRChalky joint effusion.The result of massive synovial deposition of calcium apatite in progressive systemic sclerosis. Arthritis Rheum1977;20:(3)792-796
27.
HerrickALMooreTLMurrayAKet al.Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia.Rheumatology (Oxford)2010;49:(9)1776-1782
28.
MouthonLMestre-StanislasCBéreznéAet al.Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis.Ann Rheum Dis2010;69:(1)214-217
29.
KoutaissoffSVanthuyneMSmithVet al.Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations.Semin Arthritis Rheum2011;40:(5)455-460
30.
JohnstoneEMHutchinsonCEVailAChevanceAHerrickALAcro-osteolysis in systemic sclerosis is associated with digital ischaemia and severe calcinosis.Rheumatology (Oxford)2012;51:(12)2234-2238
31.
DaviesCAHerrickALCordingleyLFreemontAJJeziorskaMExpression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis.Rheumatology (Oxford)2009;48:(8)876-882
32.
DaviesCAJeziorskaMFreemontAJHerrickALThe differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.Hum Pathol2006;37:(2)190-197
33.
GauharRWilkinsonJHarrisJManningJHerrickALCalcinosis preferentially affects the thumb compared to other fingers in patients with systemic sclerosis.Scand J Rheumatol2016;45:(4)317-320
34.
FrinkRJCalcification: a physiologic defense. In: Frink RJ, ed. Inflammatory atherosclerosis: characteristics of the injurious agent.Ch 5.Sacramento (CA)Heart Research Foundation2002. Available from: http://www.ncbi.nlm.nih.gov/books/NBK2015. Accessed Jun 20, 2016.
35.
ProudfootDShanahanCMMolecular mechanisms mediating vascular calcification: role of matrix Gla protein.Nephrology (Carlton)2006;11:(5)455-461
36.
DaviesCAJeziorskaMFreemontAJHerrickALExpression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.Rheumatology (Oxford)2006;45:(11)1349-1355
37.
KawakamiTSomaYMizoguchiMSaitoRImmunohistochemical expression of transforming growth factor beta3 in calcinosis in a patient with systemic sclerosis and CREST syndrome.Br J Dermatol2000;143:(5)1098-1100
38.
BelloliLUghiNMassarottiMMarasiniBBiondiMLBrambillaGRole of fetuin-A in systemic sclerosis-associated calcinosis.J Rheumatol2010;37:(12)2638-2639
39.
DovioADataVCarignolaRet al.Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis.J Rheumatol2008;35:(11)2206-2213
40.
NdipAWilkinsonFLJudeEBBoultonAJAlexanderMYRANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy.Diabetologia2014;57:(11)2251-2260
41.
LerouxJ-LPernotFFedouPet al.Ultrastructural and crystallographic study of calcifications from a patient with CREST syndrome.J Rheumatol1983;10:(2)242-246
42.
DemerLLTintutYVascular calcification: pathobiology of a multifaceted disease.Circulation2008;117:(22)2938-2948
43.
LinSYBiochemical and molecular aspects of spectral diagnosis in calcinosis cutis.Expert Rev Mol Med2014;16e6
44.
BrazzelliVDell'OrboCBorroniGet al.The role of the intercellular matrix in dermal calcinosis of the CRST syndrome.An electron-microscopic study. Am J Dermatopathol1992;14:(1)42-49
45.
ChungLValenzuelaAFiorentinoDet al;Scleroderma Clinical Trials Consortium Calcinosis Working Group.Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosis. Arthritis Care Res (Hoboken)2015;67:(3)425-430
46.
AudemardASilvaNMBoutemyJMaignéGBienvenuBTumoral calcinosis during the course of systemic sclerosis.J Rheumatol2015;42:(2)348
47.
HsuVBramwitMSchlesingerNUse of dual-energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosis.Clin Rheumatol2015;34:(9)1557-1561
48.
FreireVBecceFFeydyAet al.MDCT imaging of calcinosis in systemic sclerosis.Clin Radiol2013;68:(3)302-309
49.
FreireVBazeliRElhaiMet al.Hand and wrist involvement in systemic sclerosis: US features.Radiology2013;269:(3)824-830
ReiterNEl-ShabrawiLLeinweberBBergholdAAbererECalcinosis cutis: part II.Treatment options. J Am Acad Dermatol2011;65:(1)15-22quiz 23-24.
52.
DaoussisDAntonopoulosILiossisSNYiannopoulosGAndonopoulosAPTreatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature.Semin Arthritis Rheum2012;41:(6)822-829
53.
GutierrezAJrWetterDACalcinosis cutis in autoimmune connective tissue diseases.Dermatol Ther2012;25:(2)195-206
54.
BienvenuBTraitement des calcinoses sous-cutanées des connectivites.Rev Med Interne2014;35:(7)444-452
55.
DimaABalanescuPBaicusCPharmacological treatment in calcinosis cutis associated with connective-tissue diseases.Rom J Intern Med2014;52:(2)55-67
56.
ValenzuelaAChungLCalcinosis: pathophysiology and management.Curr Opin Rheumatol2015;27:(6)542-548
57.
BergerRGFeatherstoneGLRaaschRHMcCartneyWHHadlerNMTreatment of calcinosis universalis with low-dose warfarin.Am J Med1987;83:(1)72-76
58.
CukiermanTElinavEKoremMChajek-ShaulTLow dose warfarin treatment for calcinosis in patients with systemic sclerosis.Ann Rheum Dis2004;63:(10)1341-1343
59.
PalaniswamyCSekhriAAronowWSKalraAPetersonSJAssociation of warfarin use with valvular and vascular calcification: a review.Clin Cardiol2011;34:(2)74-81
60.
BalinSJWetterDAAndersenLKDavisMDCalcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.Arch Dermatol2012;148:(4)455-462
61.
DolanALKassimosDGibsonTKingsleyGHDiltiazem induces remission of calcinosis in scleroderma.Br J Rheumatol1995;34:(6)576-578
62.
PalmieriGMSebesJIAelionJAet al.Treatment of calcinosis with diltiazem.Arthritis Rheum1995;38:(11)1646-1654
63.
RobertsonLPMarshallRWHicklingPTreatment of cutaneous calcinosis in limited systemic sclerosis with minocycline.Ann Rheum Dis2003;62:(3)267-269
64.
Marco PucheACalvo PenadesILopez MontesinosBEffectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis.Clin Exp Rheumatol2010;28:(1)135-140
65.
MartillottiJMooteDZemelLImprovement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.Pediatr Radiol2014;44:(1)115-118
66.
MalbosSUrena-TorresPCohen-SolalMet al.Sodium thiosulphate treatment of uraemic tumoral calcinosis.Rheumatology (Oxford)2014;53:(3)547-551
RatsimbazafyVBahansCGuigonisVDramatic diminution of a large calcification treated with topical sodium thiosulfate.Arthritis Rheum2012;64:(11)3826
71.
PagniniISimoniniGGianiTet al.Sodium thiosulfate for the treatment of calcinosis secondary to juvenile dermatomyositis.Clin Exp Rheumatol2014;32:(3)408-409
72.
de PaulaDRKlemFBLorencettiPGMullerCAzevedoVFRituximab-induced regression of CREST-related calcinosis.Clin Rheumatol2013;32:(2)281-283
73.
GiuggioliDLumettiFColaciMFallahiPAntonelliAFerriCRituximab in the treatment of patients with systemic sclerosis.Our experience and review of the literature. Autoimmun Rev2015;14:(11)1072-1078
74.
HurabielleCAllanoreYKahanAAvouacJFlare of calcinosis despite rituximab therapy.Semin Arthritis Rheum2014;44:(2)e5-e6
75.
TosounidouSMacDonaldHSitunayakeDSuccessful treatment of calcinosis with infliximab in a patient with systemic sclerosis/myositis overlap syndrome.Rheumatology (Oxford)2014;53:(5)960-961
76.
BottomleyWWGoodfieldMJSheehan-DareRADigital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser.Br J Dermatol1996;135:(2)302-304
77.
ChamberlainAJWalkerNPSuccessful palliation and significant remission of cutaneous calcinosis in CREST syndrome with carbon dioxide laser.Dermatol Surg2003;29:(9)968-970
78.
SparsaALesauxNKesslerEet al.Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave lithotripsy.J Am Acad Dermatol2005;535 Suppl 1S263-S265
79.
Sultan-BichatNMenardJPerceauGStaermanFBernardPReguiaïZTreatment of calcinosis cutis by extracorporeal shock-wave lithotripsy.J Am Acad Dermatol2012;66:(3)424-429
80.
BogochERGrossDKSurgery of the hand in patients with systemic sclerosis: outcomes and considerations.J Rheumatol2005;32:(4)642-648
